NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDNatalizumab Tysabri® Malignant disease and immunosuppression, Natalizumab, 08.02.04
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Natalizumab Natalizumab Immune System, Immune System Disorders And Transplantation, Multiple Sclerosis, Immunosuppressants Monoclonal Antibodies
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
MHRA Drug Safety Update (April 2016) - Natalizumab (Tysabri▼): progressive multifocal leukoencephalopathy—updated advice to support early detection
NICE TA127: Multiple sclerosis - natalizumab